OPTImaL:Optimisation of Treatment for Patients With Low Stage Triple-negative Breast Cancer With High Stromal Tumor-infiltrating Lymphocytes
Clinical trial NCT06476119 · RECRUITING
Trial details
- NCT number
- NCT06476119
- Sponsor
- The Netherlands Cancer Institute
- Status
- RECRUITING
- Study type
- OBSERVATIONAL
- Start date
- 2025-04-15
- Primary completion
- 2032-09-15
- Enrollment
- 490
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.